1. Acknowledgement to Referees

   Acknowledgement to Referees 23 November 2022 Pages: 1643 - 1647

2. Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology

   • Maaike A. C. Bruin
   • Gabe S. Sonke
   • Alwin D. R. Huitema

   Review Article Open access 11 October 2022 Pages: 1649 - 1675

   

3. Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review

   • Majdoleen Alalawneh
   • Ahmed Awaisu
   • Ousama Rachid

   Systematic Review Open access 06 October 2022 Pages: 1677 - 1695

   

4. A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021

   • Li-Feng Hsu

   Original Research Article 31 October 2022 Pages: 1697 - 1703

   

5. Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care

   • Joyce E. M. van der Heijden
   • Jolien J. M. Freriksen
   • Saskia N. de Wildt

   Original Research Article Open access 11 November 2022 Pages: 1705 - 1717

   

6. Application of a Volumetric Absorptive Microsampling (VAMS)-Based Method for the Determination of Paracetamol and Four of its Metabolites as a Tool for Pharmacokinetic Studies in Obese and Non-Obese Patients

   • Laura Boffel
   • Lisa Delahaye
   • Christophe P. Stove

   Original Research Article 01 December 2022 Pages: 1719 - 1733

   

7. Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations

   • Linda B. S. Aulin
   • Sebastian T. Tandar
   • J. G. Coen van Hasselt

   Original Research Article Open access 19 November 2022 Pages: 1735 - 1748

   

8. DeepIDC: A Prediction Framework of Injectable Drug Combination Based on Heterogeneous Information and Deep Learning

   • Yuhe Yang
   • Dong Gao
   • Kejun Deng

   Original Research Article 11 November 2022 Pages: 1749 - 1759

   

9. The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

   • Ariel R. Topletz-Erickson
   • Anthony J. Lee
   • Christopher J. Endres

   Original Research Article Open access 05 December 2022 Pages: 1761 - 1770

   

10. Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies

    • David Joseph
    • Christian Thoma
    • Xiujiang Li

    Original Research Article Open access 01 December 2022 Pages: 1771 - 1787

    

11. Assessment of Aging-Related Function Variations of P-gp Transporter in Old-Elderly Chinese CHF Patients Based on Modeling and Simulation

    • Cheng Cui
    • Yuchen Qu
    • Dongyang Liu

    Original Research Article 15 November 2022 Pages: 1789 - 1800